Italy
Review Article
Malignant Pleural Mesothelioma: Management and Role of Radiation Therapy
Author(s): Donato V, Dognini J, Arcangeli S, Melis E and Facciolo FDonato V, Dognini J, Arcangeli S, Melis E and Facciolo F
Malignant pleural mesothelioma is a neoplasm derived from the mesothelial surfaces of the pleura. There are tree different mesothelioma types: Epithelioid Mesothelioma; Sarcomatoid; Biphasic /Mixed Mesothelioma. Patients with mesothelioma have a poor prognosis with a median survival ranging from 6 to 18 months depending on the stage of the disease at the time of diagnosis.
Standard Management: For patients with clinical stage I-III and Epithelial or Mixed histology who are considered medically fit, surgery is recommended with extrapleural pnemonectomy (EPP) or pleurectomy/decortication (P/D). Adjuvant radiation therapy is recommended for patients with good performance status: the goal of adjuvant radiotherapy is to improve local control and it is an effective palliative treatment for relief of chest pain associated with meso.. Read More»
DOI:
10.4172/2155-9619.S2-011
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report